The problem with treating sinusitis against the background of allergic rhinitis
https://doi.org/10.21518/2079-701X-2019-8-110-114
Abstract
Both allergic rhinitis (AR) and sinusitis are widespread diseases that significantly worsen the patient’s quality of life, lead to significant financial costs and are associated with a huge health burden. When treating any AS, it is necessary to follow three basic principles: address the cause of the disease; eradicate the pathogen; restore drainage of sinuses, aerate and restore CO. The efficacy and speed in the treatment of sinusitis, which arose against the background of allergic inflammation, are comparable to those in the use of oral GCS (Ib level, persuasion scale A). The H1-histamine receptor blocker and competitive histamine antagonist ebastine is one of the most effective and safe latest-generation antihistamine.
About the Authors
A. I. KryukovRussian Federation
Honoured Scientist of the Russian Federation, Prof., Dr. of Sci. (Med.), Chief External Expert in Otorhinolaryngology, Moscow Healthcare Department, Director State Budgetary Healthcare Institution «Sverzhevsky Scientific and Research Otolaryngology Clinical Institute» of Moscow Healthcare Department
A. B. Turovsky
Russian Federation
Dr. of Sci. (Med.), Deputy Director for Medical Affairs State Budgetary Healthcare Institution «Sverzhevsky Scientific and Research Otolaryngology Clinical Institute» of Moscow Healthcare Department
I. G. Kolbanova
Russian Federation
Cand. of Sci. (Med.), Senior Researcher, Research Department of Upper Respiratory Tract Pathology and Rhinofacial Surgery State Budgetary Healthcare Institution «Sverzhevsky Scientific and Research Otolaryngology Clinical Institute» of Moscow Healthcare Department
Yu. V. Luchsheva
Russian Federation
Cand. of Sci.(Med.), Lead Researcher, Research Department of Laryngeal Microsurgery and Phoniatrics State Budgetary Healthcare Institution «Sverzhevsky Scientific and Research Otolaryngology Clinical Institute» of Moscow Healthcare Department
K. M. Musaev
Russian Federation
a postgraduate student of Department of Upper Respiratory Tract Pathology and Rhinofacial Aesthetic Surgery State Budgetary Healthcare Institution «Sverzhevsky Scientific and Research Otolaryngology Clinical Institute» of Moscow Healthcare Department
A. B. Karasov
Russian Federation
a postgraduate student of Department of Upper Respiratory Tract Pathology and Rhinofacial Aesthetic Surgery State Budgetary Healthcare Institution «Sverzhevsky Scientific and Research Otolaryngology Clinical Institute» of Moscow Healthcare Department
References
1. Kirtsreesakul V., Naclerio R.M. Role of allergy in rhinosinusitis. Curr Opin Allergy Clin Immunol. 2004;4(1):17–23.
2. Dykewicz M.S., Hamilos D.L. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125(Suppl 2).
3. Foden N., Burgess C., Shepherd K., Almeyda R. A guide to the management of acute rhinosinusitis in primary care: management strategy based on best evidence and recent European guidelines. Br J Gen Pract. 2013;63(616):611– 613.
4. Ahmad N., Zacharek M.A. Allergic rhinitis and rhinosinusitis. Otolaryngol Clin North Am. 2008;41(2):267–281.
5. Clinical guidelines. Acute sinusitis. 2016: 30.] (In Russ.)
6. Leo G., Incorvaia C., Cazzavillan A., Consonni D., Zuccotti G.V. Could seasonal allergy be a risk factor for acute rhinosinusitis in children? J Laryngol Otol. 2018:132(2);150–153. Doi: 10.1017/S0022215118000038.
7. Bachert C. Holtappels G. Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14:Doc09.
8. Hideyuki Kawauchi, Kazuhiko Yanai, De-Yun Wang, Koju Itahashi, and Kimihiro Okubo . Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties. Int J Mol Sci. 2019 Jan;20(1):213.
9. Wang X.Y., Lim-Jurado M., Prepageran N., Tantilipikorn P., Wang de Y. Treatment of allergic rhinitis and urticaria: A review of the newest antihistamine drug bilastine. Ther. Clin. Risk Manag. 2016;12:585–597.
10. García-Gea C., Martínez-Colomer J., Antonijoan R.M., Valiente R., Barbanoj M.J. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1antihistamine: A dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments. J. Clin. Psychopharmacol. 2008;28:675–685.
11. Alho O.P., Karttunen T.J., Karttunen R., Tuokko H., Koskela M., Suramo I. et al. Subjects with allergic rhinitis show signs of more severely impaired paranasal sinus functioning during viral colds than nonallergic subjects. Allergy. 2003;58(8):767–771.
12. Turovsky A.B., Kolbanova I.G. Macrolides in the treatment of the respiratory tract infections from the perspective of the ENT doctor: «for» and «against.» Consilium Medicum. 2010;4:11-14.] (In Russ.)
13. Kozlov R.S., Garashchenko T.I., Geppe N.A., Gomberg M.A., Zimina V.N., Karpova E.P., Lapina T.L., Ovchinnikov A.Yu., Ryazantsev S.V., Svistushkin V.M., Sinopalnikov A.I. The role and place of modern macrolides in the treatment of bacterial infections. Lechaschiy Vrach. 2014;4.] (In Russ.)
14. Turovsky A.B., Kolbanova I.G., Kudryavtseva Yu.S. Evidence-based approach to the treatment of acute sinusitis. Consilium Medicum. 2018;20(3):85-89.] (In Russ.)
Review
For citations:
Kryukov AI, Turovsky AB, Kolbanova IG, Luchsheva YV, Musaev KM, Karasov AB. The problem with treating sinusitis against the background of allergic rhinitis. Meditsinskiy sovet = Medical Council. 2019;(8):110-114. (In Russ.) https://doi.org/10.21518/2079-701X-2019-8-110-114